Patient Guide: Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 14 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03614234
Status: ACTIVE_NOT_RECRUITING
Condition: Fabry Disease
Phase: PHASE3

Find a Study Location Near You

This study is available at 14 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Atlanta, Georgia
  • Iowa City, Iowa
  • • And 11 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily